UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005893
Receipt number R000006959
Scientific Title Effect of Rikkunshito administration in gastric cancer patients After gastrectomy
Date of disclosure of the study information 2011/06/30
Last modified on 2015/12/14 00:12:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Rikkunshito administration in gastric cancer patients After gastrectomy

Acronym

Effect of Rikkunshito administration in gastric cancer patients After gastrectomy

Scientific Title

Effect of Rikkunshito administration in gastric cancer patients After gastrectomy

Scientific Title:Acronym

Effect of Rikkunshito administration in gastric cancer patients After gastrectomy

Region

Japan


Condition

Condition

Gastric cancer patients after gastrectomy

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the effect of rikkunshito on gastrointestinal disorder in gastric cancer patients after gastrectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of gastrointestinal disorder

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Rikkunshito

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patientswho underwent gastrectomy
2. Written informed consent
3. Patients who is judged byinvestigator to be able to receive the protocol therapy
4. Age; 20<=, <80
5. ECOG performance status 0-1

Key exclusion criteria

1. Severe allergic reaction
2. Simultaneous or metachronous double cancers
3. Patients treated by chemotherapy
4. Any other cases who are regarded as inadequate for study enrollment by the investigator

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuichiro Doki

Organization

Division of Gastroenterological Surgery, Department of Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan

Division name

Division of Gastroenterological Surgery

Zip code


Address

2-2, E2, Yamadaoka, Suita, Osaka 565-0871, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Osakauniversity

Division name

Gastroenterological Surgery

Zip code


Address

2-2, E2, Yamadaoka, Suita, Osaka 565-0871, Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Division of Gastroenterological Surgery, Department of Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan

Institute

Department

Personal name



Funding Source

Organization

Division of Gastroenterological Surgery, Department of Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学消化器外科学


Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The present study demonstrated a significant attenuation of gastrointestinal symptoms after gastrectomy by treatment with rikkunshito. Rikkunshito is potentially useful to minimize gastrointestinal symptoms after gastrectomy.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 01 Month 30 Day

Date of IRB


Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date

2011 Year 10 Month 30 Day

Date of closure to data entry

2011 Year 10 Month 30 Day

Date trial data considered complete

2011 Year 11 Month 30 Day

Date analysis concluded

2011 Year 12 Month 31 Day


Other

Other related information

Gastric Cancer. 2013 Apr;16(2):167-74. doi: 10.1007/s10120-012-0164-3. Epub 2012 Aug 16.


Management information

Registered date

2011 Year 06 Month 30 Day

Last modified on

2015 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006959


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name